Chemed Corporation (NYSE:CHE) Receives $501.50 Consensus PT from Brokerages

Shares of Chemed Corporation (NYSE:CHEGet Free Report) have been given an average rating of “Hold” by the six analysts that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $501.50.

Several equities research analysts have recently issued reports on CHE shares. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a report on Saturday. Royal Bank Of Canada increased their price target on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Finally, Oppenheimer reduced their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th.

View Our Latest Research Report on CHE

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 3.33% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Monetary Solutions Ltd purchased a new position in shares of Chemed in the 4th quarter valued at $25,000. Los Angeles Capital Management LLC purchased a new position in shares of Chemed in the 4th quarter valued at $26,000. Smartleaf Asset Management LLC increased its holdings in shares of Chemed by 71.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after acquiring an additional 25 shares during the period. BOK Financial Private Wealth Inc. purchased a new position in shares of Chemed in the 4th quarter valued at $27,000. Finally, First Horizon Corp purchased a new position in shares of Chemed in the 3rd quarter valued at $31,000. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Price Performance

NYSE:CHE opened at $439.70 on Friday. The firm has a market capitalization of $5.83 billion, a price-to-earnings ratio of 23.96, a PEG ratio of 1.66 and a beta of 0.54. Chemed has a 1 year low of $365.20 and a 1 year high of $581.20. The business has a 50 day simple moving average of $400.27 and a 200-day simple moving average of $425.05. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83.

Chemed (NYSE:CHEGet Free Report) last posted its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.30 by $0.35. The business had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same period last year, the company earned $5.63 EPS. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Equities analysts forecast that Chemed will post 22.3 EPS for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Thursday, May 28th will be issued a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Thursday, May 28th. Chemed’s dividend payout ratio is presently 13.08%.

Chemed Company Profile

(Get Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Featured Stories

Analyst Recommendations for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.